Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole Phase 1 Study in Japanese Subjects
NCT03260595Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AN2728 ointment vehicle in atopic dermatitis (AD) (2 arms), sponsored by Pfizer. Primary endpoints: Skin Irritation Index at Day 4, Number of Participants With Treatment-Emergent Adverse Events (AEs) And Serious Adverse Events (SAEs) and 3 more. Started Sep 2017; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03260595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260595.